<DOC>
	<DOCNO>NCT00159419</DOCNO>
	<brief_summary>The study design evaluate efficacy safety `` Bisphosphonate Therapy Osteogenesis Imperfecta ( OI ) . '' We , researcher Indiana University School Medicine , characterize change effect oral bisphosphonate therapy compare regimen intravenous bisphosphonate therapy group child OI also child disorder result low bone mass fracture .</brief_summary>
	<brief_title>Bisphosphonate Therapy Osteogenesis Imperfecta</brief_title>
	<detailed_description>The study design evaluate efficacy safety `` Bisphosphonate Therapy Osteogenesis Imperfecta ( OI ) . '' OI inherit disorder collagen synthesis . Collagen major structural protein matrix tendon , skin , bone . Affected person low bone mineral density ( experience multiple fracture progressive bony deformity ) . In severe form , disorder lethal infancy . We plan characterize change effect oral bisphosphonate therapy compare regimen intravenous bisphosphonate therapy group child OI . Additionally , begin treat patient OI condition low bone mineralization age eligible standard protocol ( young , history abdominal pain , etc . ) bisphosphonate . We also plan screen parent sibling patient diagnose osteogenesis imperfecta , order determine also osteoporosis .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteogenesis Imperfecta</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Osteitis Deformans</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>Diagnosis OI , define genetic analysis reveal defect type I collagen , OR bone mineral density ( BMD ) &lt; 2.5 standard deviation ( SD ) age plus two following : Family history OI Frequent fracture Blue sclerae Multiple wormian bone skull xray Hearing disturbance Dentogenesis imperfecta Age 3 21 year start study period . Children must able swallow whole tablet Parents child must able understand protocol give inform consent . Therapy bisphosphonates past 12 month . Other `` nontraditional '' therapy OI last 6 month , growth hormone anabolic steroid . Other chronic disease besides OI interfere bone morphology gastrointestinal absorption</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Osteogenesis Imperfecta</keyword>
	<keyword>Fractures</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Juvenile Pagets</keyword>
</DOC>